An invaluable resource for clinicians who want to stay ahead of the curve in this rapidly evolving area, Psychedelics: A Clinical Guide, by Dr. Samoon Ahmad, provides essential information on the status of current clinical studies and information on the pharmacology of psychedelics. Global investigations, task forces, and legislative bodies are currently addressing the use of psychedelic substances for the treatment of addiction, depression, anxiety, and posttraumatic stress disorder, but most clinicians know very little about these treatment options. This timely resource addresses what clinicians need to know in a concise, easy-to-digest format, perfect for psychiatrists, psychiatric nurse practitioners, physician assistants, and primary care providers at all levels of experience and training.
1. 1 Introduction - p. 1 2. 2 Global History of Psychedelics - p. 13 3. 3 Clinical History - p. 26 4. 4 Regulations - p. 46 5. 5 The Psychedelic Experience - p. 60 6. 6 Psychedelic-Assisted Psychotherapy - p. 75 7. 7 How Psychedelics Affect the Brain - p. 84 8. 8 Potential Clinical Indications - p. 95 9. 9 Psilocybin - p. 119 10. 10 Lysergic Acid Diethylamide - p. 155 11. 11 N,N-Dimethyltryptamine (DMT) and Ayahuasca - p. 171 12. 12 Mescaline - p. 190 13. 13 Ibogaine - p. 209 14. 14 Ketamine - p. 229 15. 15 3,4-Methylenedioxymethamphetamine - p. 267 16. 16 Miscellaneous Psychedelics - p. 289 17. 17 Patient Stories - p. 300 18. 18 Conclusion - p. 311 19. About the Author - p. 315 20. Index - p. 317
No hay muestra disponible
No hay ficha técnica disponible
An invaluable resource for clinicians who want to stay ahead of the curve in this rapidly evolving area, Psychedelics: A Clinical Guide, by Dr. Samoon Ahmad, provides essential information on the status of current clinical studies and information on the pharmacology of psychedelics. Global investigations, task forces, and legislative bodies are currently addressing the use of psychedelic substances for the treatment of addiction, depression, anxiety, and posttraumatic stress disorder, but most clinicians know very little about these treatment options. This timely resource addresses what clinicians need to know in a concise, easy-to-digest format, perfect for psychiatrists, psychiatric nurse practitioners, physician assistants, and primary care providers at all levels of experience and training.
1. 1 Introduction - p. 1 2. 2 Global History of Psychedelics - p. 13 3. 3 Clinical History - p. 26 4. 4 Regulations - p. 46 5. 5 The Psychedelic Experience - p. 60 6. 6 Psychedelic-Assisted Psychotherapy - p. 75 7. 7 How Psychedelics Affect the Brain - p. 84 8. 8 Potential Clinical Indications - p. 95 9. 9 Psilocybin - p. 119 10. 10 Lysergic Acid Diethylamide - p. 155 11. 11 N,N-Dimethyltryptamine (DMT) and Ayahuasca - p. 171 12. 12 Mescaline - p. 190 13. 13 Ibogaine - p. 209 14. 14 Ketamine - p. 229 15. 15 3,4-Methylenedioxymethamphetamine - p. 267 16. 16 Miscellaneous Psychedelics - p. 289 17. 17 Patient Stories - p. 300 18. 18 Conclusion - p. 311 19. About the Author - p. 315 20. Index - p. 317
No hay muestra disponible
No hay ficha técnica disponible
